Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-12-16
1991-07-16
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514419, 514423, 514561, 514562, 514565, 514824, A61K 31415, A61K 3140, A61K 31195
Patent
active
050326082
ABSTRACT:
A method and substrate composition for treating atherosclerosis are provided. The method involves parenterally administering the substrate composition as an aqueous solution to substantially lower plasma cholesterol and substantially reverse arterial plaque deposition and degenerative changes associated with atherosclerosis. The substrate compositions include mixtures of biologically active levorotatory amino acids as the antiatherosclerotic agent.
REFERENCES:
patent: 2411897 (1947-12-01), Sahyun
patent: 2457820 (1949-01-01), Howe et al.
patent: 2965542 (1960-12-01), Castaigne
patent: 3574857 (1971-04-01), Cevallos
patent: 3764703 (1973-10-01), Bergstrom et al.
patent: 3832465 (1974-08-01), Ghadimi
patent: 3920838 (1975-11-01), Flatt et al.
patent: 3950529 (1976-04-01), Fisher et al.
patent: 4103021 (1978-07-01), Carr
patent: 4167562 (1979-09-01), Evers
patent: 4430338 (1984-02-01), Jansen et al.
patent: 4532129 (1988-07-01), Comi et al.
patent: 4604286 (1986-08-01), Kawajiri
"Crystalline Amino Acid Solutions-Travasol.RTM." in AMA Drug Evaluations (1980) Chicago 4th, Edition.
Kritchevsky, D. Atherosclerosis, 49: 209-10 (1983).
Sanchez, A. et al., Nutrition Reports Intn. 28(3) 497-508 (1983).
O'Donnell, J. et al., Southern Med. J. 76, No. 11, 1344-48(1983).
Dudrick, S., et al., Surgery 64, No.11 (1986), 134-42.
Dudrick, S. J. Parenteral Nutr., 1, No. 1, 23-29 (1977).
Dudrick, S. J. Parenteral Enterol. Nutr. 3, No. 6 (1979) 444-51.
Dudrick, S., Annals of Surgery, 199, No. 6(1984) 770-81.
Dudrick, S., Arch. Surg. 120 (1985) 721-27.
Katan, M., et al., Atherosclerosis, 43 (1982), 381-92.
Kritchevsky, D. et al., Soy Protein Prev. Atherosclar., Proc. Int. Symp., 4th (1982), 1-11.
West, C. et al., Atherosclersosis, 47 (1983), 263-70.
Boers, G. et al. J. Clin. Inv., 72 (1983) 1971-76.
Sugano, M., et al., Ann. Nutr. Metab., 28(1984), 192-99.
Redgrave, T. G., et al., Atherosclerosis 52(1984), 349-51.
Dudrick et al., Fed. Proc., 43, No. 7 (1984) Abstract #3537.
Dudrick, D., et al., J. Par. and Ent. Nutr. 9, No. 1(1985) 116.
Sugiyma, K. et al., J. Nutr. Sci., 32(6) 623-33 (1986).
Perl, M. et al., Psychosomatics, 22 No. 12 (1981).
Dudrick, S., Brochure of USV Labs (1982) "Parental Nutrition for Hospitalized Patient, Case Studies in Parenteral Nutrition", No. 3, A Severely Burned Patient.
Dudrick, S., et al. 13th International Cancer Congress, Part. D 161-70.
Dudrick, S. et al., Contemporary OB/GYN Special Issue, Update on General Surgery (1983) 95-96, 101-03.
Dudrick, S., et al., Heart and Lung, 12, No. 2 (1983) 195-201.
Schwartz, R. G. et al. "Regulation of Myocardial Amino Acid Balance in the Conscious Dog." J. Clin. Invest., 75 (1985), 1204-11.
Yagasaki, K., et al. "Serum and Liver Lipid Responses to Methionine and Cystine in Rats Fed Diets with Different Casein Levels".
Nutrition Reports International, 34, No. 1 (Jul. 1986), 59-66.
Kramer, J. H., et al. "Effect of Taurine on Calcium Paradox and Ischemic Heart Failure." Am. J. Physiol., 240 (Heart Circ. Physiol. 9) (1981), H238-H246.
Azuma, J., et al. "Taurine and Failing Heart: Experimental and Clinical Aspects." Taurine: Biological Actions and Clinical Perspectives, (1985), 195-213.
Kritchevsky, D., et al., "Experimental Atherosclerosis in Rabbits Fed Cholesterol-Free Diets." Atherosclerosis, 26 (1977), 397-403.
Kritchevsky, D., et al. "Experimental Atherosclerosis in Rabbits Fed Cholesterol-Free Diets." Atherosclerosis, 39 (1981), 169-75.
Kritchevsky, D., et al. "Atherogenicity of Animal and Vegetable Protein." Atherosclerosis, 41 (1982), 429-431.
Friedman Stanley J.
Henley, III. Raymond J.
LandOfFree
Method and substrate composition for treating atherosclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and substrate composition for treating atherosclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and substrate composition for treating atherosclerosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-132145